Zach is a biopharmaceutical inventor, entrepreneur and executive. He has served as the COO and a Director of PaxMedica since March 2019. Zach is also a Partner at TardiMed Sciences, a life sciences company creation firm. At TardiMed, Zach has helped to form several life sciences companies that span multiple therapeutic areas and stages of development. Most recently, Zach was the Co-Founder, President, and Director of Timber Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases.
Previously, Zach was the Co-Founder and President at Patagonia Pharmaceuticals, a privately-owned specialty pharmaceutical company developing treatments for rare dermatologic diseases. He was the lead inventor on all of Patagonia’s technologies and oversaw their development from concept through Phase 2 studies. In 2018, Patagonia was awarded a $1.5 million grant from the FDA for which Zach served as the Principal Investigator. Zach has a BS in Marine Science and Biology from the University of Miami and an MST in Adolescent Science Biology from Pace University.